Inhibition of IgE-mediated mast cell degranulation by sulphasalazine
- 1 January 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 107 (2) , 279-281
- https://doi.org/10.1016/0014-2999(85)90071-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Mast cell heterogeneity: Evidence and implicationsJournal of Clinical Immunology, 1984
- Histamine release from the cultured mouse mast cell line PT 18 in response to immunologic and non-immunologic stimuliInflammation Research, 1984
- The mucosal mast cell and its role in gastrointestinal allergic diseasesClinical Reviews in Allergy, 1984
- Mast cells isolated from guinea-pig lung: characterization and studies on histamine secretionInflammation Research, 1983
- Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitisBiochemical Pharmacology, 1983
- Sulfasalazine IntoleranceScandinavian Journal of Gastroenterology, 1982
- THE EFFECT OF ALKALINE EARTH CATIONS ON THE RELEASE OF HISTAMINE FROM RAT PERITONEAL MAST CELLS TREATED WITH COMPOUND 48/80 AND PEPTIDE 401British Journal of Pharmacology, 1979
- Modulation of Cyclic AMP in Purified Rat Mast CellsThe Journal of Immunology, 1975
- Distribution Studies of Salicylazosulfapyridine and its MetabolitesGastroenterology, 1973
- Salazopyrin, a new sulfanilamide preparation. A. Therapeutic Results in Rheumatic Polyarthritis. B. Therapeutic Results in Ulcerative Colitis. C. Toxic Manifestations in Treatment with Sulfanilamide Preparations.Acta Medica Scandinavica, 1942